Cite

    Toyama, K. et al. (n.d.). Single‐dose evaluation of safety, tolerability and pharmacokinetics of newly formulated hydromorphone immediate‐release and hydrophilic matrix extended‐release tablets in healthy Japanese subjects without co‐administration of an opioid antagonist. Journal of clinical pharmacology. pp. 975-984. [Online].